We are live on
!
Find out more
MCM
Marsico Capital Management Portfolio holdings
AUM
$3.4B
1-Year Est. Return
51.58%
This Fund
S&P 500
This Quarter
Est. Return
+6.47%
1 Year Est. Return
+51.58%
3 Year Est. Return
+243.93%
5 Year Est. Return
+321.58%
10 Year Est. Return
+1,831.46%
AUM
$15.9B
AUM Growth
–
Cap. Flow
+$15.9B
Cap. Flow
% of AUM
99.53%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
97
New
97
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$888M |
| 2 |
Biogen
BIIB
|
+$854M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$688M |
| 4 |
MON
Monsanto Co
MON
|
+$612M |
| 5 |
Citigroup
C
|
+$580M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.56% |
| 2 | Financials | 15.96% |
| 3 | Healthcare | 13.37% |
| 4 | Industrials | 12.33% |
| 5 | Communication Services | 11.68% |
Similar funds
BG
OAM
DFO
VFCM
CCM
CIA
EFM
JGC
Marsico Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Marsico Capital Management, which disclosed 97 positions worth $15.9B. Its ten largest holdings account for 37% of the portfolio.
Its largest position is Gilead Sciences: 17,041,344 shares worth $873M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, followed by Financials and Healthcare.
- Marsico Capital Management's largest Q2 2013 buy was Gilead Sciences: 17,041,344 shares worth $873M.
- Marsico Capital Management's ten largest holdings make up 37% of its $15.9B portfolio in Q2 2013.
- Marsico Capital Management disclosed 97 positions in Q2 2013, its first 13F filing on record.
Based on Marsico Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.